Biomarkers along the continuum of care in lung cancer

Blood-based biomarkers are valuable diagnostic tools for the management of lung cancer patients. They support not only differential diagnosis and histological subtyping, but are also applied for estimation of prognosis, stratification for specific therapies, monitoring of therapy response, surveilla...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Scandinavian journal of clinical & laboratory investigation. Supplement Ročník 76; číslo 45; s. S40 - S45
Hlavný autor:	Holdenrieder, Stefan
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Norway Taylor & Francis 13.07.2016
Predmet:	Antigens, Neoplasm - blood Antigens, Neoplasm - genetics Antineoplastic Agents - therapeutic use Biomarker Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Carcinoembryonic Antigen - blood Carcinoembryonic Antigen - genetics diagnosis DNA, Neoplasm - blood DNA, Neoplasm - genetics Early Diagnosis Gene Expression Regulation, Neoplastic Humans Keratin-19 - blood Keratin-19 - genetics liquid profiling lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Peptide Fragments - blood Peptide Fragments - genetics personalized medicine Phosphopyruvate Hydratase - blood Phosphopyruvate Hydratase - genetics Prognosis Recombinant Proteins - blood Recombinant Proteins - genetics Serpins - blood Serpins - genetics serum Transcriptome Treatment Outcome lung cancer liquid profiling diagnosis Biomarker serum personalized medicine
ISSN:	0036-5513, 2166-1030, 1502-7686, 2166-1030
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!